Elysia Creative Biology, Inc.
New Form D on file · 2026-02-11 · the record
What the record says
Trailing twelve months. 716 filings in Biotechnology, totalled by week. The dot is this raise, $465K, on the same scale — one filing against the whole group's total, so it sits low by construction.
Use of proceeds, as written on the filing
Proceeds to be used for working capital, which may include compensation to executive officers in the ordinary course of business.
Company officers on record
Eli Hornstein is named as Executive Officer and Director and Promoter on the Form D that Elysia Creative Biology, Inc. filed with the SEC on 11 February 2026, the only person that filing names.
1 person named on the filing — 1 holding an executive role.
Named as of the 2026-02-11 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
The full profile
Source Check, INVEST, RECRUIT and Press Requests on Elysia Creative Biology, Inc.
- Source Check — verify Eli Hornstein's other claims against the registers that hold them.
- INVEST — size up this raise on the figures the filing states.
- RECRUIT — see who is already on the team.
- Press Requests — connect with Eli Hornstein for a story.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Elysia Creative Biology, Inc.You get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind Elysia Creative Biology, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. FoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.